You are here:HomeNews CenterInsurance News2017Report Recommends Actions by Insurers in Opioid Crisis

Report Recommends Actions by Insurers in Opioid Crisis

A report from the National Academies of Sciences, Engineering, and Medicine indicates that reversing the effects of the opioid abuse epidemic will require coordinated efforts among regulators and insurance companies...
July 18, 2017

A report from the National Academies of Sciences, Engineering, and Medicine indicates that reversing the effects of the opioid abuse epidemic will require coordinated efforts among regulators and insurance companies. The study was sponsored by the U.S. Food and Drug Administration (FDA).

The report suggests that public and private payers, including insurance companies, should develop reimbursement models that support evidence-based and cost-effective comprehensive pain management, including both drug and nondrug treatments for pain. It also recommended that public and private payers, including insurance companies, should develop reimbursement models that support evidence-based and cost-effective comprehensive pain management, including both drug and non-drug treatments for pain.

“The broad reach of the epidemic has blurred the formerly distinct social boundary between prescribed opioids and illegally manufactured ones, such as heroin,” said committee chair Richard J. Bonnie, Harrison Foundation Professor of Medicine and Law and director of the Institute of Law, Psychiatry, and Public Policy at the University of Virginia in Charlottesville.

Filed under: